Skip to main content
  1. Home
  2. Search

Search

Enter the terms you wish to search for.

Search results

3 results found

BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models.

Publication: Journal Article
Rauh, Ulrike, Guo Wei, Michael Serrano-Wu, Georgios Kosmidis, Stefan Kaulfuss, Franziska Siegel, Kai Thede, et al. 2024. “BRD-810 Is a Highly Selective MCL1 Inhibitor With Optimized in Vivo Clearance and Robust Efficacy in Solid and Hematological Tumor Models.”. Nat Cancer 5: 1479-93.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Publication: Book
Driscoll, Adam. 2020. Lorem Ipsum Dolor Sit Amet, Consectetur Adipiscing Elit, Sed Do Eiusmod Tempor Incididunt Ut Labore et Dolore Magna Aliqua.. Publihser’s Name.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua

Publication: Website
Hallman, Mitchell, Adam Driscoll, Ryan Lubbe, and . 2020. “Lorem Ipsum Dolor Sit Amet, Consectetur Adipiscing Elit, Sed Do Eiusmod Tempor Incididunt Ut Labore et Dolore Magna Aliqua.”

Current search

  • Search found 3 items
  • (-) Publication
  • (-) 2024
  • (-) Sep 2024

Sort by

  • Relevance
  • Title
  • Type
  • Date

Filter By Post Date

  • (-) 2024
  • (-) Sep 2024
  • Sep 03, 2024 (2)
  • Sep 18, 2024 (1)

Filter By Post Type

  • (-) Publication
No filters available

Filter By Other Sites

  • The Richard N. Merkin Prize in Biomedical Technology (2)
  • Golub Lab (1)

Filter By Taxonomy

No filters available
Powered byOpenScholar®Admin Login